Status:
COMPLETED
Understanding Clinician Utilization of Corus CAD (Age/Sex/Gene Expression Score - ASGES) in Clinical Decision Making
Lead Sponsor:
CardioDx
Conditions:
Coronary Artery Disease
Angina Pectoris
Eligibility:
All Genders
21-99 years
Brief Summary
The purpose of this study is to understand the use of Corus CAD also known as Age/Sex/Gene Expression score (ASGES) in the clinical decision making process of patients who underwent the evaluation of ...
Detailed Description
The UCU-CARD (Understanding Clinician Utility-Cardiology) study is a retrospective, matched-cohort evaluation of diagnostic testing in a community-based cardiology practice setting that used a persona...
Eligibility Criteria
Inclusion
- Symptoms suggestive of CAD, according to the opinion of the site clinician
- Age \>= 21 years
Exclusion
- History of myocardial infarction (MI)
- History of high risk unstable angina, systemic infections or systemic inflammatory conditions
- Current MI or acute coronary syndrome
- Current New York Heart Association (NYHA) class III or IV congestive heart failure symptoms
- Known/documented CAD
- History/current Diabetes Mellitus
- Taking steroids, immunosuppressive agents, or chemotherapeutic agents, at time of chest pain presentation
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
552 Patients enrolled
Trial Details
Trial ID
NCT02223286
Start Date
March 1 2013
End Date
August 1 2014
Last Update
February 22 2018
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
John C. Lincoln Heart Institute
Phoenix, Arizona, United States, 85037
2
Piedmont Heart Institute
Blue Ridge, Georgia, United States, 30513
3
Heart Associates
Youngstown, Ohio, United States, 44504